Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 14.53%42.67B | -10.69%10.16B | 89.54%15.29B | 5.89%37.26B | -11.16%11.38B | 4.37%7.74B | 61.85%10.08B | -7.72%8.07B | 27.84%35.19B | 3.78%12.8B |
Cost of revenue | 17.63%35.59B | -7.85%8.78B | 89.87%12.33B | 2.38%30.26B | -13.48%9.53B | 3.08%6.39B | 52.09%7.85B | -9.61%6.5B | 33.23%29.56B | 12.22%11.01B |
Gross profit | 1.11%7.08B | -25.35%1.38B | 88.15%2.96B | 24.34%7B | 3.16%1.85B | 10.93%1.35B | 108.93%2.24B | 0.99%1.57B | 5.43%5.63B | -29.05%1.79B |
Operating expense | 12.19%4.58B | 10.81%1.32B | 30.24%1.12B | 19.26%4.08B | 7.20%1.19B | 40.31%1.05B | 24.36%983.56M | 11.08%859.46M | 5.37%3.42B | -5.03%1.11B |
Operating profit | -14.38%2.5B | -91.27%57.07M | 158.12%1.84B | 32.20%2.92B | -3.48%653.63M | -35.60%303.27M | 348.68%1.25B | -9.00%711.29M | 5.53%2.21B | -49.87%677.17M |
Net non-operating interest income (expenses) | -15.04%-321.89M | -9.40%-86.42M | -25.97%-76.11M | -19.49%-279.8M | -22.29%-79M | -21.41%-75.28M | -14.70%-65.11M | -18.95%-60.42M | -6.90%-234.16M | -10.95%-64.6M |
Non-operating interest income | -47.11%119K | -71.62%42K | 1,000.00%11K | 268.85%225K | 362.50%148K | 1,300.00%14K | 158.33%62K | -75.00%1K | -24.69%61K | 3.23%32K |
Non-operating interest expense | 14.99%322M | 9.25%86.46M | 25.98%76.12M | 19.56%280.02M | 22.46%79.15M | 21.43%75.29M | 14.76%65.17M | 18.94%60.42M | 6.88%234.22M | 10.94%64.63M |
Net investment income | 51.46%5.6M | 0 | 78,400.00%2.36M | 26.93%3.7M | 0 | 26.92%3.7M | 1K | 50.00%3K | 100.21%2.92M | 1K |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -125.08%-112.54M | -50M | 0 | |||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -14.55M | 0 | 16.02M | |||||||
Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---16.02M | ---- |
Less:Other special charges | --14.55M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -94.40%-146.41M | -69.67%-65.38M | -229.05%-9.41M | -27.94%-75.31M | -983.88%-38.53M | -140.81%-14.92M | 40.78%-19M | 83.20%-2.86M | 30.50%-58.86M | 89.20%-3.56M |
Income before tax | -24.15%1.91B | -145.63%-221.82M | 170.49%1.75B | 30.18%2.52B | -22.23%486.1M | -46.56%216.77M | 514.07%1.17B | -9.22%648.01M | 8.03%1.93B | -50.44%625.04M |
Income tax | -14.95%787.41M | -67.15%64.36M | 188.34%586.07M | 30.36%925.79M | -24.14%195.94M | -42.07%85.76M | 475.85%440.84M | -10.58%203.26M | 14.42%710.19M | -41.62%258.28M |
Net income | -29.50%1.12B | -198.62%-286.17M | 162.33%1.17B | 30.08%1.59B | -20.88%290.17M | -49.14%131.01M | 539.82%726.87M | -8.58%444.75M | 4.65%1.22B | -55.20%366.76M |
Net income continuous operations | -29.50%1.12B | -198.62%-286.17M | 162.33%1.17B | 30.08%1.59B | -20.88%290.17M | -49.14%131.01M | 539.82%726.87M | -8.58%444.75M | 4.65%1.22B | -55.20%366.76M |
Noncontrolling interests | -38.22%10M | -35.31%5.68M | -88.31%573K | 119.09%16.19M | -22.34%8.78M | 510.10%1.26M | 170.16%1.25M | 366.90%4.9M | 7.39M | 11.31M |
Net income attributable to the company | -29.41%1.11B | -203.72%-291.86M | 165.13%1.17B | 29.54%1.58B | -20.84%281.38M | -49.69%129.75M | 528.90%725.62M | -9.93%439.85M | 4.01%1.22B | -56.58%355.45M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -29.41%1.11B | -203.72%-291.86M | 165.13%1.17B | 29.54%1.58B | -20.84%281.38M | -49.69%129.75M | 528.90%725.62M | -9.93%439.85M | 4.01%1.22B | -56.58%355.45M |
Gross dividend payment | ||||||||||
Basic earnings per share | -29.14%76.5 | -203.91%-20.085 | 166.46%80.205 | 29.43%107.96 | -20.55%19.33 | -49.67%8.885 | 530.01%49.645 | -10.27%30.1 | 3.15%83.41 | -56.97%24.33 |
Diluted earnings per share | -28.93%76.345 | -203.91%-20.085 | 166.88%79.865 | 29.66%107.42 | -20.55%19.33 | -49.67%8.885 | 530.01%49.645 | -9.95%29.925 | 3.29%82.85 | -56.97%24.33 |
Dividend per share | 20 | 20 | ||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |